Denali Therapeutics

Denali Therapeutics

Biotechnology Research

South San Francisco, California 44,187 followers

Defeat Degeneration

About us

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development. Our team thrives in a work environment that is scientifically driven, impact-focused, supportive, and collaborative. Our ability to have a positive impact on people’s lives is directly related to the trust we have in each other and our ability to unify our diverse backgrounds and experience behind our purpose to defeat degeneration.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
South San Francisco, California
Type
Public Company
Founded
2015
Specialties
Biotechnology, Neurodegenerative Disease, Neurodegeneration, and Pharmaceuticals

Locations

  • Primary

    161 Oyster Point Blvd

    South San Francisco, California 94080, US

    Get directions

Employees at Denali Therapeutics

Updates

Similar pages

Browse jobs

Funding

Denali Therapeutics 6 total rounds

Last Round

Post IPO equity

US$ 500.0M

See more info on crunchbase